0001593968-20-000375.txt : 20200210
0001593968-20-000375.hdr.sgml : 20200210
20200210170201
ACCESSION NUMBER: 0001593968-20-000375
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200206
FILED AS OF DATE: 20200210
DATE AS OF CHANGE: 20200210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MICHEL GERARD J
CENTRAL INDEX KEY: 0001235644
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35280
FILM NUMBER: 20592796
MAIL ADDRESS:
STREET 1: 420 CHIPETA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vericel Corp
CENTRAL INDEX KEY: 0000887359
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943096597
STATE OF INCORPORATION: MI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 7349305555
MAIL ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC
DATE OF NAME CHANGE: 19960428
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2020-02-06
0000887359
Vericel Corp
VCEL
0001235644
MICHEL GERARD J
C/O VERICEL CORPORATION
64 SIDNEY STREET
CAMBRIDGE
MA
02139
false
true
false
false
CFO and VP, Corp. Development
Common Stock
2020-02-06
4
M
false
3000
0
A
162732
D
Common Stock
2020-02-06
4
F
false
1460
17.28
D
161272
D
Restricted Stock Unit
2020-02-06
4
M
false
3000
17.28
D
Common Stock
3000
9000
D
The shares of common stock were acquired by the Reporting person as a result of the vesting of RSUs granted to the Reporting Person on February 6, 2019. The remaining RSUs will vest in annual installments on February 6, 2021, February 6, 2022, and February 6, 2023, respectively.
These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of Restricted Stock Units.
Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 6, 2019. The remaining RSUs will vest in annual installments on February 6, 2021, February 6, 2022, and February 6, 2023, respectively.
No expiration date for this type of award.
/s/ Gerard Michel
2020-02-10